BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

415 related articles for article (PubMed ID: 11277619)

  • 1. IL-12 prevents tolerance induction with mouse thyroglobulin by priming pathogenic T cells in experimental autoimmune thyroiditis: role of IFN-gamma and the costimulatory molecules CD40l and CD28.
    Zhang W; Flynn JC; Kong YC
    Cell Immunol; 2001 Feb; 208(1):52-61. PubMed ID: 11277619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circumvention of the induction of resistance in murine experimental autoimmune thyroiditis by recombinant IL-1 beta.
    Nabozny GH; Kong YC
    J Immunol; 1992 Aug; 149(3):1086-92. PubMed ID: 1634763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Noninvolvement of IL-4 and IL-10 in tolerance induction to experimental autoimmune thyroiditis.
    Zhang W; Kong YC
    Cell Immunol; 1998 Aug; 187(2):95-102. PubMed ID: 9732697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD40L is necessary for the priming of effector cells for lymphocytic and granulomatous experimental autoimmune thyroiditis.
    Peterson KE; Braley-Mullen H
    J Autoimmun; 1999 Feb; 12(1):1-12. PubMed ID: 10028017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of granulomatous experimental autoimmune thyroiditis in mice with in vitro activated effector T cells and anti-IFN-gamma antibody.
    Stull SJ; Sharp GC; Kyriakos M; Bickel JT; Braley-Mullen H
    J Immunol; 1992 Sep; 149(6):2219-26. PubMed ID: 1517579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of granulomatous experimental autoimmune thyroiditis in IL-4 gene-disrupted mice.
    Tang H; Sharp GC; Peterson KE; Braley-Mullen H
    J Immunol; 1998 Jan; 160(1):155-62. PubMed ID: 9551967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinctive modulation by IL-4 and IL-10 of the effector function of murine thyroglobulin-primed cells in "transfer-experimental autoimmune thyroiditis".
    Mignon-Godefroy K; Brazillet MP; Rott O; Charreire J
    Cell Immunol; 1995 May; 162(2):171-7. PubMed ID: 7743543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergism between mouse thyroglobulin- and vaccination-induced suppressor mechanisms in murine experimental autoimmune thyroiditis.
    Nabozny GH; Flynn JC; Kong YC
    Cell Immunol; 1991 Sep; 136(2):340-8. PubMed ID: 1831404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous administration of deaggregated mouse thyroglobulin suppresses induction of experimental autoimmune thyroiditis and expression of both Th1 and Th2 cytokines.
    Tang H; Braley-Mullen H
    Int Immunol; 1997 May; 9(5):679-87. PubMed ID: 9184913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A thyroxine-containing thyroglobulin peptide induces both lymphocytic and granulomatous forms of experimental autoimmune thyroiditis.
    Braley-Mullen H; Sharp GC
    J Autoimmun; 1997 Dec; 10(6):531-40. PubMed ID: 9451592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of resistance to murine experimental autoimmune thyroiditis: duration and afferent action of thyroglobulin- and TSH-induced suppression.
    Fuller BE; Okayasu I; Simon LL; Giraldo AA; Kong YM
    Clin Immunol Immunopathol; 1993 Oct; 69(1):60-8. PubMed ID: 7691454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IFN-gamma-deficient mice develop severe granulomatous experimental autoimmune thyroiditis with eosinophil infiltration in thyroids.
    Tang H; Sharp GC; Peterson KP; Braley-Mullen H
    J Immunol; 1998 May; 160(10):5105-12. PubMed ID: 9590262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential requirement for autoantibody-producing B cells for induction of lymphocytic versus granulomatous experimental autoimmune thyroiditis.
    Braley-Mullen H; Sharp GC; Kyriakos M
    J Immunol; 1994 Jan; 152(1):307-14. PubMed ID: 8254200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of the induction and resolution of granulomatous experimental autoimmune thyroiditis in mice by CD8+ T cells.
    Braley-Mullen H; McMurray RW; Sharp GC; Kyriakos M
    Cell Immunol; 1994 Feb; 153(2):492-504. PubMed ID: 8118878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of immune tolerance in mice with a novel mucosal nanoemulsion adjuvant and self-antigen.
    Wang SH; Fan Y; Makidon PE; Cao Z; Baker JR
    Nanomedicine (Lond); 2012 Jun; 7(6):867-76. PubMed ID: 22420425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effects of CD28 engagement and IL-12 on T cell activation by altered peptide ligands.
    Ding L; Shevach EM
    J Immunol; 1998 Dec; 161(12):6614-21. PubMed ID: 9862689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-12 promotes activation of effector cells that induce a severe destructive granulomatous form of murine experimental autoimmune thyroiditis.
    Braley-Mullen H; Sharp GC; Tang H; Chen K; Kyriakos M; Bickel JT
    Am J Pathol; 1998 May; 152(5):1347-58. PubMed ID: 9588903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interference with CD4+CD25+ T-cell-mediated tolerance to experimental autoimmune thyroiditis by glucocorticoid-induced tumor necrosis factor receptor monoclonal antibody.
    Morris GP; Kong YC
    J Autoimmun; 2006 Feb; 26(1):24-31. PubMed ID: 16253477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human thyroglobulin peptide p2340 induces autoimmune thyroiditis in HLA-DR3 transgenic mice.
    Karras E; Yang H; Lymberi P; Christadoss P
    J Autoimmun; 2005 Jun; 24(4):291-6. PubMed ID: 15927791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Participation of Vbeta13(+) and Vbeta1(+) T cells in transfer thyroiditis after activation of mouse thyroglobulin-primed T cells by superantigen staphylococcal enterotoxin A.
    Wan Q; Kita M; Flynn JC; Panos JC; Motte RW; Davies TF; Giraldo AA; David CS; Kong YC
    Cell Immunol; 2001 Nov; 213(2):149-57. PubMed ID: 11831877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.